Safety Assessment of Over-the-counter Personal Care and Cosmetic Products Ingredients Based on Product Description

March 18, 2025 updated by: Muhammad Naveed Babur, Superior University

Safety Assessment of Over-the-counter Personal Care and Cosmetic Products Ingredients Based on Product Description and Properties

"Personal care and cosmetic products maintain hygiene, enhance aesthetics and promote wellbeing. This category includes various formulations for cleansing, grooming and beautification products for skin, hair, nails, lips and teeth.

Study Overview

Status

Completed

Detailed Description

This study evaluates the safety of ingredients in 100 over the counter personal care and cosmetic products. Stratified sampling selects products from various categories, brands and retailers.

Study Type

Observational

Enrollment (Actual)

100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Punjab
      • Lahore, Punjab, Pakistan
        • Pharmacies (Mehmood Pharmacy, Servaid Pharmacy, Clinix+ Pharmacy), Supermarkets (Hyperstar, Metro cash and carry, Imtiaz supermarket), Departmental stores (AL Fatah, Haji cream bakhsh, Enem store), Online retailers (Saloni.pk, Just4Girls.pk, Daraz.pk)

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Probability Sample

Study Population

Safety Assessment of Over-the-counter Personal Care and Cosmetic Products' Ingredients Based on Product Description.

Description

Inclusion Criteria:

  • Over the counter personal care products available for consumer purchase,Products from various categories (e.g., skincare, haircare, makeup, eye care),
  • Products from different brands and manufacturers,Products with ingredient labels or lists available,Products marketed for general consumer use (not specialized or prescription products).

Exclusion Criteria:

  • Prescription-only products or those requiring medical supervision,Products intended for specialized use (e.g., medical conditions, sensitive skin)
  • Products without ingredient labels or lists.
  • Products from obscure or unreliable manufacturers
  • Products with expired or near-expired ingredients.
  • Products with unclear or misleading labelling,Products not intended for general consumer use (e.g., professional salon products),Products with ingredients already known to be harmful or banned by regulatory agencies.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Likert scales
Time Frame: 12 months
Likert scales commonly comprise either five or seven options. The options on each end are called response anchors. The midpoint is often a neutral item, with positive options on one side and negative options on the other. Each item is given a score from 1 to 5 or 1 to 7
12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 28, 2024

Primary Completion (Actual)

June 22, 2024

Study Completion (Actual)

March 1, 2025

Study Registration Dates

First Submitted

December 17, 2024

First Submitted That Met QC Criteria

March 18, 2025

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

March 18, 2025

Last Verified

March 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • MSAHS/Batch-Spring23/024

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

Yes

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cosmetic Product Causing Toxic Effect

Clinical Trials on Cosmetic Products

Subscribe